Biosimilars Insulin and Forecast Market
1 Biosimilars Insulin Market Overview
1.1 Product Overview and Scope of Biosimilars Insulin
1.2 Biosimilars Insulin Segment by Type
1.2.1 Global Biosimilars Insulin Sales Growth Rate Comparison by Type (2023-2030)
1.2.2 Insulin Glargine
1.2.3 Insulin Aspart
1.2.4 Insulin Lispro
1.2.5 Other
1.3 Biosimilars Insulin Segment by Application
1.3.1 Global Biosimilars Insulin Sales Comparison by Application: (2023-2030)
1.3.2 Type I Diabetes
1.3.3 Type II Diabetes
1.4 Global Biosimilars Insulin Market Size Estimates and Forecasts
1.4.1 Global Biosimilars Insulin Revenue 2018-2030
1.4.2 Global Biosimilars Insulin Sales 2018-2030
1.4.3 Biosimilars Insulin Market Size by Region: 2018 Versus 2022 Versus 2030
2 Biosimilars Insulin Market Competition by Manufacturers
2.1 Global Biosimilars Insulin Sales Market Share by Manufacturers (2018-2023)
2.2 Global Biosimilars Insulin Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Biosimilars Insulin Average Price by Manufacturers (2018-2023)
2.4 Manufacturers Biosimilars Insulin Manufacturing Sites, Area Served, Product Type
2.5 Biosimilars Insulin Market Competitive Situation and Trends
2.5.1 Biosimilars Insulin Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Biosimilars Insulin Players Market Share by Revenue
2.5.3 Global Biosimilars Insulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Biosimilars Insulin Retrospective Market Scenario by Region
3.1 Global Biosimilars Insulin Retrospective Market Scenario in Sales by Region: 2018-2023
3.2 Global Biosimilars Insulin Retrospective Market Scenario in Revenue by Region: 2018-2023
3.3 North America Biosimilars Insulin Market Facts & Figures by Country
3.3.1 North America Biosimilars Insulin Sales by Country
3.3.2 North America Biosimilars Insulin Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Biosimilars Insulin Market Facts & Figures by Country
3.4.1 Europe Biosimilars Insulin Sales by Country
3.4.2 Europe Biosimilars Insulin Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Biosimilars Insulin Market Facts & Figures by Region
3.5.1 Asia Pacific Biosimilars Insulin Sales by Region
3.5.2 Asia Pacific Biosimilars Insulin Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Biosimilars Insulin Market Facts & Figures by Country
3.6.1 Latin America Biosimilars Insulin Sales by Country
3.6.2 Latin America Biosimilars Insulin Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Biosimilars Insulin Market Facts & Figures by Country
3.7.1 Middle East and Africa Biosimilars Insulin Sales by Country
3.7.2 Middle East and Africa Biosimilars Insulin Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Biosimilars Insulin Historic Market Analysis by Type
4.1 Global Biosimilars Insulin Sales Market Share by Type (2018-2023)
4.2 Global Biosimilars Insulin Revenue Market Share by Type (2018-2023)
4.3 Global Biosimilars Insulin Price by Type (2018-2023)
5 Global Biosimilars Insulin Historic Market Analysis by Application
5.1 Global Biosimilars Insulin Sales Market Share by Application (2018-2023)
5.2 Global Biosimilars Insulin Revenue Market Share by Application (2018-2023)
5.3 Global Biosimilars Insulin Price by Application (2018-2023)
6 Key Companies Profiled
6.1 Eli Lilly
6.1.1 Eli Lilly Corporation Information
6.1.2 Eli Lilly Description and Business Overview
6.1.3 Eli Lilly Biosimilars Insulin Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Eli Lilly Biosimilars Insulin Product Portfolio
6.1.5 Eli Lilly Recent Developments/Updates
6.2 Boehringer Ingelheim
6.2.1 Boehringer Ingelheim Corporation Information
6.2.2 Boehringer Ingelheim Description and Business Overview
6.2.3 Boehringer Ingelheim Biosimilars Insulin Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Boehringer Ingelheim Biosimilars Insulin Product Portfolio
6.2.5 Boehringer Ingelheim Recent Developments/Updates
6.3 Biocon/Mylan
6.3.1 Biocon/Mylan Corporation Information
6.3.2 Biocon/Mylan Description and Business Overview
6.3.3 Biocon/Mylan Biosimilars Insulin Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Biocon/Mylan Biosimilars Insulin Product Portfolio
6.3.5 Biocon/Mylan Recent Developments/Updates
6.4 Gan & Lee Pharmaceuticals
6.4.1 Gan & Lee Pharmaceuticals Corporation Information
6.4.2 Gan & Lee Pharmaceuticals Description and Business Overview
6.4.3 Gan & Lee Pharmaceuticals Biosimilars Insulin Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Gan & Lee Pharmaceuticals Biosimilars Insulin Product Portfolio
6.4.5 Gan & Lee Pharmaceuticals Recent Developments/Updates
6.5 Tonghua Dongbao
6.5.1 Tonghua Dongbao Corporation Information
6.5.2 Tonghua Dongbao Description and Business Overview
6.5.3 Tonghua Dongbao Biosimilars Insulin Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Tonghua Dongbao Biosimilars Insulin Product Portfolio
6.5.5 Tonghua Dongbao Recent Developments/Updates
6.6 United Laboratories
6.6.1 United Laboratories Corporation Information
6.6.2 United Laboratories Description and Business Overview
6.6.3 United Laboratories Biosimilars Insulin Sales, Revenue and Gross Margin (2018-2023)
6.6.4 United Laboratories Biosimilars Insulin Product Portfolio
6.6.5 United Laboratories Recent Developments/Updates
6.7 Sanofi
6.6.1 Sanofi Corporation Information
6.6.2 Sanofi Description and Business Overview
6.6.3 Sanofi Biosimilars Insulin Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Sanofi Biosimilars Insulin Product Portfolio
6.7.5 Sanofi Recent Developments/Updates
7 Biosimilars Insulin Manufacturing Cost Analysis
7.1 Biosimilars Insulin Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Biosimilars Insulin
7.4 Biosimilars Insulin Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Biosimilars Insulin Distributors List
8.3 Biosimilars Insulin Customers
9 Biosimilars Insulin Market Dynamics
9.1 Biosimilars Insulin Industry Trends
9.2 Biosimilars Insulin Market Drivers
9.3 Biosimilars Insulin Market Challenges
9.4 Biosimilars Insulin Market Restraints
10 Global Market Forecast
10.1 Biosimilars Insulin Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Biosimilars Insulin by Type (2023-2030)
10.1.2 Global Forecasted Revenue of Biosimilars Insulin by Type (2023-2030)
10.2 Biosimilars Insulin Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Biosimilars Insulin by Application (2023-2030)
10.2.2 Global Forecasted Revenue of Biosimilars Insulin by Application (2023-2030)
10.3 Biosimilars Insulin Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Biosimilars Insulin by Region (2023-2030)
10.3.2 Global Forecasted Revenue of Biosimilars Insulin by Region (2023-2030)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Biosimilars Insulin Sales Growth Rate Comparison by Type (2023-2030) & (K Units) & (US$ Million)
Table 2. Global Biosimilars Insulin Sales Growth Rate Comparison by Application (2023-2030) & (K Units) & (US$ Million)
Table 3. Global Biosimilars Insulin Market Size by Region (US$ Million) (2018 VS 2022 VS 2030)
Table 4. Global Biosimilars Insulin Market Competitive Situation by Manufacturers in 2022
Table 5. Global Biosimilars Insulin Sales (K Units) of Key Manufacturers (2018-2023)
Table 6. Global Biosimilars Insulin Sales Market Share by Manufacturers (2018-2023)
Table 7. Global Biosimilars Insulin Revenue (US$ Million) by Manufacturers (2018-2023)
Table 8. Global Biosimilars Insulin Revenue Share by Manufacturers (2018-2023)
Table 9. Global Market Biosimilars Insulin Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 10. Manufacturers Biosimilars Insulin Manufacturing Sites and Area Served
Table 11. Manufacturers Biosimilars Insulin Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Biosimilars Insulin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilars Insulin as of 2022)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Biosimilars Insulin Sales by Region (2018-2023) & (K Units)
Table 16. Global Biosimilars Insulin Sales Market Share by Region (2018-2023)
Table 17. Global Biosimilars Insulin Revenue by Region (2018-2023) & (US$ Million)
Table 18. Global Biosimilars Insulin Revenue Market Share by Region (2018-2023)
Table 19. North America Biosimilars Insulin Sales by Country (2018-2023) & (K Units)
Table 20. North America Biosimilars Insulin Sales Market Share by Country (2018-2023)
Table 21. North America Biosimilars Insulin Revenue by Country (2018-2023) & (US$ Million)
Table 22. North America Biosimilars Insulin Revenue Market Share by Country (2018-2023)
Table 23. Europe Biosimilars Insulin Sales by Country (2018-2023) & (K Units)
Table 24. Europe Biosimilars Insulin Sales Market Share by Country (2018-2023)
Table 25. Europe Biosimilars Insulin Revenue by Country (2018-2023) & (US$ Million)
Table 26. Europe Biosimilars Insulin Revenue Market Share by Country (2018-2023)
Table 27. Asia Pacific Biosimilars Insulin Sales by Region (2018-2023) & (K Units)
Table 28. Asia Pacific Biosimilars Insulin Sales Market Share by Region (2018-2023)
Table 29. Asia Pacific Biosimilars Insulin Revenue by Region (2018-2023) & (US$ Million)
Table 30. Asia Pacific Biosimilars Insulin Revenue Market Share by Region (2018-2023)
Table 31. Latin America Biosimilars Insulin Sales by Country (2018-2023) & (K Units)
Table 32. Latin America Biosimilars Insulin Sales Market Share by Country (2018-2023)
Table 33. Latin America Biosimilars Insulin Revenue by Country (2018-2023) & (US$ Million)
Table 34. Latin America Biosimilars Insulin Revenue Market Share by Country (2018-2023)
Table 35. Middle East and Africa Biosimilars Insulin Sales by Country (2018-2023) & (K Units)
Table 36. Middle East and Africa Biosimilars Insulin Sales Market Share by Country (2018-2023)
Table 37. Middle East and Africa Biosimilars Insulin Revenue by Country (2018-2023) & (US$ Million)
Table 38. Middle East and Africa Biosimilars Insulin Revenue Market Share by Country (2018-2023)
Table 39. Global Biosimilars Insulin Sales by Type (2018-2023) & (K Units)
Table 40. Global Biosimilars Insulin Sales Market Share by Type (2018-2023)
Table 41. Global Biosimilars Insulin Revenue by Type (2018-2023) & (US$ Million)
Table 42. Global Biosimilars Insulin Revenue Share by Type (2018-2023)
Table 43. Global Biosimilars Insulin Price by Type (2018-2023) & (USD/Unit)
Table 44. Global Biosimilars Insulin Sales (K Units) by Application (2018-2023)
Table 45. Global Biosimilars Insulin Sales Market Share by Application (2018-2023)
Table 46. Global Biosimilars Insulin Revenue by Application (2018-2023) & (US$ Million)
Table 47. Global Biosimilars Insulin Revenue Share by Application (2018-2023)
Table 48. Global Biosimilars Insulin Price by Application (2018-2023) & (USD/Unit)
Table 49. Eli Lilly Corporation Information
Table 50. Eli Lilly Description and Business Overview
Table 51. Eli Lilly Biosimilars Insulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 52. Eli Lilly Biosimilars Insulin Product
Table 53. Eli Lilly Recent Developments/Updates
Table 54. Boehringer Ingelheim Corporation Information
Table 55. Boehringer Ingelheim Description and Business Overview
Table 56. Boehringer Ingelheim Biosimilars Insulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 57. Boehringer Ingelheim Biosimilars Insulin Product
Table 58. Boehringer Ingelheim Recent Developments/Updates
Table 59. Biocon/Mylan Corporation Information
Table 60. Biocon/Mylan Description and Business Overview
Table 61. Biocon/Mylan Biosimilars Insulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 62. Biocon/Mylan Biosimilars Insulin Product
Table 63. Biocon/Mylan Recent Developments/Updates
Table 64. Gan & Lee Pharmaceuticals Corporation Information
Table 65. Gan & Lee Pharmaceuticals Description and Business Overview
Table 66. Gan & Lee Pharmaceuticals Biosimilars Insulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 67. Gan & Lee Pharmaceuticals Biosimilars Insulin Product
Table 68. Gan & Lee Pharmaceuticals Recent Developments/Updates
Table 69. Tonghua Dongbao Corporation Information
Table 70. Tonghua Dongbao Description and Business Overview
Table 71. Tonghua Dongbao Biosimilars Insulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 72. Tonghua Dongbao Biosimilars Insulin Product
Table 73. Tonghua Dongbao Recent Developments/Updates
Table 74. United Laboratories Corporation Information
Table 75. United Laboratories Description and Business Overview
Table 76. United Laboratories Biosimilars Insulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 77. United Laboratories Biosimilars Insulin Product
Table 78. United Laboratories Recent Developments/Updates
Table 79. Sanofi Corporation Information
Table 80. Sanofi Description and Business Overview
Table 81. Sanofi Biosimilars Insulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 82. Sanofi Biosimilars Insulin Product
Table 83. Sanofi Recent Developments/Updates
Table 84. Production Base and Market Concentration Rate of Raw Material
Table 85. Key Suppliers of Raw Materials
Table 86. Biosimilars Insulin Distributors List
Table 87. Biosimilars Insulin Customers List
Table 88. Biosimilars Insulin Market Trends
Table 89. Biosimilars Insulin Market Drivers
Table 90. Biosimilars Insulin Market Challenges
Table 91. Biosimilars Insulin Market Restraints
Table 92. Global Biosimilars Insulin Sales Forecast by Type (2023-2030) & (K Units)
Table 93. Global Biosimilars Insulin Sales Market Share Forecast by Type (2023-2030)
Table 94. Global Biosimilars Insulin Revenue Forecast by Type (2023-2030) & (US$ Million)
Table 95. Global Biosimilars Insulin Revenue Market Share Forecast by Type (2023-2030)
Table 96. Global Biosimilars Insulin Sales Forecast by Application (2023-2030) & (K Units)
Table 97. Global Biosimilars Insulin Sales Market Share Forecast by Application (2023-2030)
Table 98. Global Biosimilars Insulin Revenue Forecast by Application (2023-2030) & (US$ Million)
Table 99. Global Biosimilars Insulin Revenue Market Share Forecast by Application (2023-2030)
Table 100. Global Biosimilars Insulin Sales Forecast by Region (2023-2030) & (K Units)
Table 101. Global Biosimilars Insulin Sales Market Share Forecast by Region (2023-2030)
Table 102. Global Biosimilars Insulin Revenue Forecast by Region (2023-2030) & (US$ Million)
Table 103. Global Biosimilars Insulin Revenue Market Share Forecast by Region (2023-2030)
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Biosimilars Insulin
Figure 2. Global Biosimilars Insulin Market Share by Type in 2022 & 2030
Figure 3. Insulin Glargine Product Picture
Figure 4. Insulin Aspart Product Picture
Figure 5. Insulin Lispro Product Picture
Figure 6. Other Product Picture
Figure 7. Global Biosimilars Insulin Market Share by Application in 2022 & 2030
Figure 8. Type I Diabetes
Figure 9. Type II Diabetes
Figure 10. Global Biosimilars Insulin Revenue, (US$ Million), 2018 VS 2022 VS 2030
Figure 11. Global Biosimilars Insulin Market Size (2018-2030) & (US$ Million)
Figure 12. Global Biosimilars Insulin Sales (2018-2030) & (K Units)
Figure 13. Biosimilars Insulin Sales Share by Manufacturers in 2022
Figure 14. Global Biosimilars Insulin Revenue Share by Manufacturers in 2022
Figure 15. The Global 5 and 10 Largest Biosimilars Insulin Players: Market Share by Revenue in 2022
Figure 16. Biosimilars Insulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 17. Global Biosimilars Insulin Sales Market Share by Region (2018-2023)
Figure 18. Global Biosimilars Insulin Sales Market Share by Region in 2022
Figure 19. Global Biosimilars Insulin Revenue Market Share by Region (2018-2023)
Figure 20. Global Biosimilars Insulin Revenue Market Share by Region in 2022
Figure 21. United States Biosimilars Insulin Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 22. Canada Biosimilars Insulin Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 23. Germany Biosimilars Insulin Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 24. France Biosimilars Insulin Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 25. U.K. Biosimilars Insulin Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 26. Italy Biosimilars Insulin Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 27. Russia Biosimilars Insulin Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 28. China Biosimilars Insulin Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 29. Japan Biosimilars Insulin Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 30. South Korea Biosimilars Insulin Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 31. India Biosimilars Insulin Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 32. Australia Biosimilars Insulin Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 33. China Taiwan Biosimilars Insulin Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 34. Indonesia Biosimilars Insulin Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 35. Thailand Biosimilars Insulin Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 36. Malaysia Biosimilars Insulin Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 37. Mexico Biosimilars Insulin Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 38. Brazil Biosimilars Insulin Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 39. Argentina Biosimilars Insulin Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 40. Colombia Biosimilars Insulin Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 41. Turkey Biosimilars Insulin Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 42. Saudi Arabia Biosimilars Insulin Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 43. UAE Biosimilars Insulin Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 44. Sales Market Share of Biosimilars Insulin by Type (2018-2023)
Figure 45. Manufacturing Cost Structure of Biosimilars Insulin
Figure 46. Manufacturing Process Analysis of Biosimilars Insulin
Figure 47. Biosimilars Insulin Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
Industry Market Size
